↓ Skip to main content

Dove Medical Press

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study

Overview of attention for article published in OncoTargets and therapy, May 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
9 Mendeley